Clinical trial
Addition of Naltrexone to Methadone Taper
NCT00135759 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00135759 |
|---|---|
| Title | Addition of Naltrexone to Methadone Taper |
| Official title | Place of Low-Dose Naltrexone in Opiate Detoxification |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heroin Dependence, Opioid-Related Disorders, Substance-Related Disorders |
| Intervention type | Drug |
| Interventions | Naltrexone, Placebo comparator, naltrexone |
| Enrollment | 174 |
| Start date | Apr 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Aug 26, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: